Company profile: Republic M
1.1 - Company Overview
Company description
- Provider of digital interactions and platforms to maximize behavioral change of healthcare professionals, including remote 1:1 selling engagements between key account managers and HCPs, peer-to-peer virtual and hybrid sessions with key opinion leaders, HCP profiling, custom portals and apps, and a SaaS platform integrating client-HCP interactions via a single interface.
Products and services
- SaaS (Software as a Service): Integrated platform that unifies client-to-HCP interactions via a single interface, streamlining engagement workflows and content access to maximize behavioral change
- Remote 1:1 Selling Engagements: Virtual 1:1 interactions between Key Account Managers and healthcare professionals to drive behavior change and improve healthcare outcomes
- HCP Profiling: Role-based identification of high-value healthcare professionals using roles and patient populations to enable targeted engagement
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Republic M
ePharma Solutions
HQ: United States
Website
- Description: Provider of e-clinical solutions that help sponsors, pharmaceutical companies, CROs, and investigator sites accelerate and improve clinical studies through better site selection, training, activation, and management. Offerings include Site Feasibility to find and activate qualified sites globally, and Rater and Patient Training to mitigate bias and variability, improving data quality and standardization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ePharma Solutions company profile →
123Compliance
HQ: United States
Website
- Description: Provider of compliance-focused solutions for the life science industry, with more than 20 years of experience. As a Salesforce partner, has built and implemented global complaint handling, quality management, regulatory reporting, and document management systems for small and large pharmaceutical and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 123Compliance company profile →
GRO Biosciences
HQ: United States
Website
- Description: Provider of protein therapeutics technology leveraging Genomically Recoded Organisms to produce non-standard amino acid proteins. Offers the GRO Platform to expand the amino acid alphabet; a Biofoundry integrating computational design and robotics; DuraLogic chemistry to enhance protein structure and duration; and ProGly to modulate immune responses, aiming to treat autoimmunity and reduce anti-drug antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GRO Biosciences company profile →
StationX
HQ: United States
Website
- Description: Provider of software products that enable scientists and clinicians to extract maximal biological meaning from complex genomic data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StationX company profile →
Prosarix
HQ: United Kingdom
Website
- Description: Provider of computational approaches and products to assist drug discovery for biotech and pharmaceutical sectors, including ProtoDiscovery, a validated, state-of-the-art computational platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prosarix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Republic M
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Republic M
2.2 - Growth funds investing in similar companies to Republic M
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Republic M
4.2 - Public trading comparable groups for Republic M
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →